3rd Annual Partnerships in Clinical Trials Asia
时间：2011年10月12日-14日
地点：上海金茂君悦大酒店，中国
Accelerating The Progress Of Clinical Trials Around The World
第三届亚洲临床试验合作年会
把握中国机遇,加快促进全球临床试验发展
MEET The largest concentration of clinical decision makers specializing in clinical development,operations and outsourcing. This is your opportunity to establish benchmarks, standards and best practices in the development and commercialization of products in a global marketplace:
●Hear in-depth case studies on strategic partnering and effective outsourcing to ensure
quality, control costs and accelerate cures to market
●Explore new business opportunities and strategies to bring more innovation to Asia
●Hear from the SFDA on updates on clinical safety and monitoring guidelines
●Understand how global clinical leaders are incorporating China into their global drug
development strategy
●Gain insights into the regulatory landscapes in Japan, India, Korea, Taiwan, China, and more
●Obtain strategies for partnering in specific therapeutic areas by hearing proven case studies in oncology, CNS, Cardiovascular, and vaccine development
●Develop strategies to improve sponsor, CRO, and site collaborations in Asia
●Learn about trends in patient recruitment efforts across the region and develop strategies to suit Asian cultures
●Examine level of data quality in the region and overcome challenges in GCP implementation
●Identify new trends in technology impacting clinical development in Asia and exchange best practices on data management
本次会议为加速亚洲创新药物发展提供了一个绝佳平台。在三天的紧凑日程中您将会见会
见大量从事临床发展、运营和外包业务的决策者。这是您在全球市场的产品开发和商业化
领域建立基准、标准和最佳实践的好机会：
◆听取有关运用战略合作和有效外包手段的深入案例研究，以确保质量，控制成本，并加
速市场药品推出
◆探索新的商业契机和战略规划，为亚洲带来更多的创新成果
◆听取SFDA（国家食品药品监督管理局）最新的临床安全和监测指导方针
◆了解全球临床实验项目领导人如何将中国纳入其全球药物研发战略
◆获取关于日本、印度、韩国、中国台湾地区和中国大陆的药品监管环境的最新资讯
◆听取肿瘤、中枢神经系统、心血管和疫苗开发领域的经过验证的案例分析，了解在具体
治疗领域缔结战略伙伴关系的策略
◆制定策略以深化亚洲临床试验承办方、CRO 和网站之间的合作
◆学习亚洲有关患者招募工作方面的发展趋势，制定适应亚洲文化的策略
◆探讨亚洲地区的数据质量管理，应对GCP（药物临床试验质量管理规范）执行方面的挑
战
◆确定影响亚洲临床发展的新技术趋势，交流数据管理的最佳实践
